Does ENHANCE diminish confidence in lowering LDL or in ezetimibe?

被引：69

作者：

Brown, B. Greg ^{[1
]}

Taylor, Allen J. ^{[2
,3
]}

机构：

[1] Univ Washington, Sch Med, Seattle, WA 98195 USA

[2] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA

[3] Walter Reed Army Med Ctr, Serv Cardiol, Washington, DC 20307 USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2008年 / 358卷 / 14期

关键词：

D O I：

10.1056/NEJMe0801608

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1504 / 1507

页数：4

共 17 条

[1] LIPID DEPLETION IN ATHEROMATOUS CORONARY-ARTERIES IN RHESUS-MONKEYS AFTER REGRESSION DIETS [J].

ARMSTRONG, ML ;

MEGAN, MB .

CIRCULATION RESEARCH, 1972, 30 (06) :675-+

[2] Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double-blind trial [J].

Bots, Michiel L. ;

Visseren, Frank L. ;

Evans, Gregory W. ;

Riley, Ward A. ;

Revkin, James H. ;

Tegeler, Charles H. ;

Shear, Charles L. ;

Duggan, William T. ;

Vicari, Ralph M. ;

Grobbee, Diederick E. ;

Kastelein, John J. .

LANCET, 2007, 370 (9582) :153-160

[3] Carotid intima-media thickness and coronary atherosclerosis: weak or strong relations? [J].

Bots, Michiel L. ;

Baldassarre, Damiano ;

Simon, Alain ;

de Groot, Eric ;

O'Leary, Daniel H. ;

Riley, Ward ;

Kastelein, John J. ;

Grobbee, Diederick E. .

EUROPEAN HEART JOURNAL, 2007, 28 (04) :398-406

[4] Simultaneous low-density lipoprotein-C lowering and high-density lipoprotein-C elevation for optimum cardiovascular disease prevention with various drug classes, and their combinations: a meta-analysis of 23 randomized lipid trials [J].

Brown, B. Greg ;

Stukovsky, Karen Hinckley ;

Zhao, Xue-Qiao .

CURRENT OPINION IN LIPIDOLOGY, 2006, 17 (06) :631-636

[5] Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease [J].

Brown, BG ;

Zhao, XQ ;

Chait, A ;

Fisher, LD ;

Cheung, MC ;

Morse, JS ;

Dowdy, AA ;

Marino, EK ;

Bolson, EL ;

Alaupovic, P ;

Frohlich, J ;

Albers, JJ ;

Serafini, L ;

Huss-Frechette, E ;

Wang, S ;

DeAngelis, D ;

Dodek, A .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (22) :1583-1592

[6] LIPID-LOWERING AND PLAQUE REGRESSION - NEW INSIGHTS INTO PREVENTION OF PLAQUE DISRUPTION AND CLINICAL EVENTS IN CORONARY-DISEASE [J].

BROWN, BG ;

ZHAO, XQ ;

SACCO, DE ;

ALBERS, JJ .

CIRCULATION, 1993, 87 (06) :1781-1791

[7] Design and rationale of the ARBITER 6 trial (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol)-6-HDL and LDL treatment strategies in atherosclerosis (HALTS) [J].

Devine, Patrick J. ;

Turco, Mark A. ;

Taylor, Allen J. .

CARDIOVASCULAR DRUGS AND THERAPY, 2007, 21 (03) :221-225

[8] Carotenoid transport is decreased and expression of the lipid transporters SR-BI, NPC1L1, and ABCA1 is downregulated in Caco-2 cells treated with ezetimibe [J].

During, Alexandrine ;

Dawson, Harry D. ;

Harrison, Earl H. .

JOURNAL OF NUTRITION, 2005, 135 (10) :2305-2312

[9] Relation of plaque lipid composition and morphology to the stability of human aortic plaques [J].

Felton, CV ;

Crook, D ;

Davies, MJ ;

Oliver, MF .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (07) :1337-1345

[10] Differential effects of short-term lipid lowering with ezetimibe and statins on endothelial function in patients with CAD:: clinical evidence for 'pleiotropic' functions of statin therapy [J].

Fichtlscherer, S ;

Schmidt-Lucke, C ;

Bojunga, S ;

Rössig, L ;

Heeschen, C ;

Dimmeler, S ;

Zeiher, AM .

EUROPEAN HEART JOURNAL, 2006, 27 (10) :1182-1190

← 1 2 →